Inactive Instrument
e-therapeutics plc Stock London S.E.
Stocks
ETX
GB00B2823H99
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -6.74% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | 2023-09-19 | |
Alan Whitmore
CTO | Chief Tech/Sci/R&D Officer | - | 2020-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Trevor Jones
CHM | Chairman | 84 | 2021-02-28 |
| Director/Board Member | 70 | 2020-02-09 | |
David Prior
CHM | Chairman | - | 2024-05-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.74% | -7.93% | - | - | 101M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 57.39B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.64B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.29B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.5B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.63% | +19.50% | 28.53B | |
| +0.05% | -1.64% | -7.28% | -14.06% | 24.34B | |
| Average | -0.88% | -0.59% | +54.39% | +120.28% | 43.39B | |
| Weighted average by Cap. | +0.12% | -0.84% | +58.77% | +129.91% |
Employees
40
